4-Methoxyisoagarotetrol

CAS No. 104901-10-2

4-Methoxyisoagarotetrol( ——— )

Catalog No. M38156 CAS No. 104901-10-2

4'-Methoxyisoagarotetrol is chromone derivative and shows moderate PDE 3A inhibitory activity (IC50=54 μM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    4-Methoxyisoagarotetrol
  • Note
    Research use only, not for human use.
  • Brief Description
    4'-Methoxyisoagarotetrol is chromone derivative and shows moderate PDE 3A inhibitory activity (IC50=54 μM).
  • Description
    4'-Methoxyisoagarotetrol is chromone derivative and shows moderate PDE3A inhibitory activity (IC50=54 μM).
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    104901-10-2
  • Formula Weight
    348.35
  • Molecular Formula
    C18H20O7
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Sugiyama, Takuji; Narukawa, Yuji; Shibata, Shunsuke; Masui, Ryo; Kiuchi, Fumiyuki (2018).?Three new 5,6,7,8-tetrahydroxy-5,6,7,8-tetrahydrochromone derivatives enantiomeric to agarotetrol from agarwood. Journal of Natural Medicines. 2018 Jun;72(3):667-674?
molnova catalog
related products
  • R 892

    Potent and selective bradykinin B1 receptor antagonist (ID50 values are 2.8 and > 600 nM at B1 and B2 receptors respectively). Exhibits no intrinsic agonist activity and is resistant to aminopeptidase and kininase II (ACE) cleavage. Displays hypertensive activity in vivo.

  • Thalidomide-O-C6-NH2...

    Thalidomide-O-C6-NH2 hydrochloride is a synthesized E3 ligase ligand-linker conjugate.

  • Gypenoside LI

    Gypenoside LI possesses non-small cell lung carcinoma A549 cell inhibitory activity.